August 21st 2025
Patients with higher exposure to nature and green spaces were significantly less likely to experience dry eye, investigators reported
AAO 2023: Company updates from Centricity Vision CEO Rob Thornhill
November 28th 2023At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.
Breaking News: FDA approves perfluorohexyloctane ophthalmic solution for dry eye disease
May 18th 2023According to Bausch + Lomb and Novaliq, MIEBO is the first prescription eye drop approved for dry eye disease that directly targets tear evaporation, based on consistent results from a pair of pivotal Phase 3 trials.